Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China

Background: For patients with symptomatic intracranial artery stenosis (sICAS), endovascular treatment has been shown to be feasible and safe in recent studies. However, in-stent restenosis (ISR) risks the recurrence of ischemic stroke. We attempt to elucidate the risk factors for ISR.Methods: We re...

Full description

Bibliographic Details
Main Authors: Xu Guo, Ning Ma, Feng Gao, Da-Peng Mo, Gang Luo, Zhong-Rong Miao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2020.601199/full
_version_ 1818725739858493440
author Xu Guo
Ning Ma
Feng Gao
Da-Peng Mo
Gang Luo
Zhong-Rong Miao
author_facet Xu Guo
Ning Ma
Feng Gao
Da-Peng Mo
Gang Luo
Zhong-Rong Miao
author_sort Xu Guo
collection DOAJ
description Background: For patients with symptomatic intracranial artery stenosis (sICAS), endovascular treatment has been shown to be feasible and safe in recent studies. However, in-stent restenosis (ISR) risks the recurrence of ischemic stroke. We attempt to elucidate the risk factors for ISR.Methods: We retrospectively analyzed 97 patients with sICAS from a prospective registry trial that included 20 centers from September 2013 to January 2015. Cases were classified into the ISR≥ 50% group or the ISR < 50% group. The baseline characteristics and long-term follow-up were compared between the two groups. Binary logistic regression analyses were identified as an association between ISR and endovascular technique factors.Results: According to whether ISR was detected by CT angiography, 97 patients were divided into the ISR group (n = 24) and the non-ISR group (n = 73). The admission baseline features and lesion angiography characteristics were similar, while plasma hs-CRP (mg/L) was higher in the ISR≥ 50% group at admission (8.2 ± 11.4 vs. 2.8 ± 4.1, p = 0.032). Binary logistic regression analysis identified the longer stents (adjusted OR 0.816, 95% CI 0.699–0.953; p = 0.010), balloon-mounted stents (adjusted OR 5.748, 95% CI 1.533–21.546; p = 0.009), and local anesthesia (adjusted OR 6.000, 95% CI 1.693–21.262; p = 0.006) as predictors of ISR at the 1-year follow-up.Conclusions: The longer stents, balloon-mounted stents implanted in the intracranial vertebral or basilar artery, and local anesthesia were significantly associated with in-stent restenosis. Further studies are required to identify accurate biomarkers or image markers associated with ISR in ICAS patients.Clinical Trial Registration:www.ClinicalTrials.gov, identifier: NCT01968122.
first_indexed 2024-12-17T21:47:06Z
format Article
id doaj.art-95b0d2a00b6541918ff27778dfd2dbb8
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-17T21:47:06Z
publishDate 2021-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-95b0d2a00b6541918ff27778dfd2dbb82022-12-21T21:31:26ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-01-011110.3389/fneur.2020.601199601199Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in ChinaXu GuoNing MaFeng GaoDa-Peng MoGang LuoZhong-Rong MiaoBackground: For patients with symptomatic intracranial artery stenosis (sICAS), endovascular treatment has been shown to be feasible and safe in recent studies. However, in-stent restenosis (ISR) risks the recurrence of ischemic stroke. We attempt to elucidate the risk factors for ISR.Methods: We retrospectively analyzed 97 patients with sICAS from a prospective registry trial that included 20 centers from September 2013 to January 2015. Cases were classified into the ISR≥ 50% group or the ISR < 50% group. The baseline characteristics and long-term follow-up were compared between the two groups. Binary logistic regression analyses were identified as an association between ISR and endovascular technique factors.Results: According to whether ISR was detected by CT angiography, 97 patients were divided into the ISR group (n = 24) and the non-ISR group (n = 73). The admission baseline features and lesion angiography characteristics were similar, while plasma hs-CRP (mg/L) was higher in the ISR≥ 50% group at admission (8.2 ± 11.4 vs. 2.8 ± 4.1, p = 0.032). Binary logistic regression analysis identified the longer stents (adjusted OR 0.816, 95% CI 0.699–0.953; p = 0.010), balloon-mounted stents (adjusted OR 5.748, 95% CI 1.533–21.546; p = 0.009), and local anesthesia (adjusted OR 6.000, 95% CI 1.693–21.262; p = 0.006) as predictors of ISR at the 1-year follow-up.Conclusions: The longer stents, balloon-mounted stents implanted in the intracranial vertebral or basilar artery, and local anesthesia were significantly associated with in-stent restenosis. Further studies are required to identify accurate biomarkers or image markers associated with ISR in ICAS patients.Clinical Trial Registration:www.ClinicalTrials.gov, identifier: NCT01968122.https://www.frontiersin.org/articles/10.3389/fneur.2020.601199/fullcerebrovascular diseasestrokeendovascular treatmentinterventional neurologyintracranial in-stent restenosis
spellingShingle Xu Guo
Ning Ma
Feng Gao
Da-Peng Mo
Gang Luo
Zhong-Rong Miao
Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
Frontiers in Neurology
cerebrovascular disease
stroke
endovascular treatment
interventional neurology
intracranial in-stent restenosis
title Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
title_full Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
title_fullStr Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
title_full_unstemmed Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
title_short Long-Term Risk Factors for Intracranial In-Stent Restenosis From a Multicenter Trial of Stenting for Symptomatic Intracranial Artery Stenosis Registry in China
title_sort long term risk factors for intracranial in stent restenosis from a multicenter trial of stenting for symptomatic intracranial artery stenosis registry in china
topic cerebrovascular disease
stroke
endovascular treatment
interventional neurology
intracranial in-stent restenosis
url https://www.frontiersin.org/articles/10.3389/fneur.2020.601199/full
work_keys_str_mv AT xuguo longtermriskfactorsforintracranialinstentrestenosisfromamulticentertrialofstentingforsymptomaticintracranialarterystenosisregistryinchina
AT ningma longtermriskfactorsforintracranialinstentrestenosisfromamulticentertrialofstentingforsymptomaticintracranialarterystenosisregistryinchina
AT fenggao longtermriskfactorsforintracranialinstentrestenosisfromamulticentertrialofstentingforsymptomaticintracranialarterystenosisregistryinchina
AT dapengmo longtermriskfactorsforintracranialinstentrestenosisfromamulticentertrialofstentingforsymptomaticintracranialarterystenosisregistryinchina
AT gangluo longtermriskfactorsforintracranialinstentrestenosisfromamulticentertrialofstentingforsymptomaticintracranialarterystenosisregistryinchina
AT zhongrongmiao longtermriskfactorsforintracranialinstentrestenosisfromamulticentertrialofstentingforsymptomaticintracranialarterystenosisregistryinchina